205 related articles for article (PubMed ID: 11227733)
1. RET proto-oncogene mutation in a mixed medullary-follicular thyroid carcinoma.
Orlandi F; Chiefari E; Caraci P; Mussa A; Gonzatto I; De Giuli P; Giuffrida D; Angeli A; Filetti S
J Endocrinol Invest; 2001 Jan; 24(1):51-5. PubMed ID: 11227733
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of the RET proto-oncogene in patients with sporadic medullary thyroid carcinoma: a novel point mutation in the extracellular cysteine-rich domain.
Bugalho MJ; Frade JP; Santos JR; Limbert E; Sobrinho L
Eur J Endocrinol; 1997 Apr; 136(4):423-6. PubMed ID: 9150704
[TBL] [Abstract][Full Text] [Related]
3. A single missense mutation in codon 918 of the RET proto-oncogene in sporadic medullary thyroid carcinomas.
Maeda S; Namba H; Takamura N; Tanigawa K; Takahashi M; Noguchi S; Nagataki S; Kanematsu T; Yamashita S
Endocr J; 1995 Apr; 42(2):245-50. PubMed ID: 7627269
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel somatic mutation in the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma.
Matias-Guiu X; Lagarda E; Calaf M; Azpiroz A; De Leiva A; Prat J; Baiget M
Hum Mutat; 1997; 9(5):476. PubMed ID: 9143934
[No Abstract] [Full Text] [Related]
5. The RET proto-oncogene in medullary and papillary thyroid carcinoma. Molecular features, pathophysiology and clinical implications.
Komminoth P
Virchows Arch; 1997 Jul; 431(1):1-9. PubMed ID: 9247627
[TBL] [Abstract][Full Text] [Related]
6. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
[TBL] [Abstract][Full Text] [Related]
7. Point mutation of the RET proto-oncogene in the TT human medullary thyroid carcinoma cell line.
Carlomagno F; Salvatore D; Santoro M; de Franciscis V; Quadro L; Panariello L; Colantuoni V; Fusco A
Biochem Biophys Res Commun; 1995 Feb; 207(3):1022-8. PubMed ID: 7864888
[TBL] [Abstract][Full Text] [Related]
8. A novel somatic mutation in the RET proto-oncogene in familial medullary thyroid carcinoma with a germline codon 768 mutation.
Miyauchi A; Egawa S; Futami H; Kuma K; Obara T; Yamaguchi K
Jpn J Cancer Res; 1997 Jun; 88(6):527-31. PubMed ID: 9263528
[TBL] [Abstract][Full Text] [Related]
9. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
Romei C; Elisei R; Pinchera A; Ceccherini I; Molinaro E; Mancusi F; Martino E; Romeo G; Pacini F
J Clin Endocrinol Metab; 1996 Apr; 81(4):1619-22. PubMed ID: 8636377
[TBL] [Abstract][Full Text] [Related]
10. A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma.
Fattoruso O; Quadro L; Libroia A; Verga U; Lupoli G; Cascone E; Colantuoni V
Hum Mutat; 1998; Suppl 1():S167-71. PubMed ID: 9452077
[No Abstract] [Full Text] [Related]
11. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.
Marsh DJ; Mulligan LM; Eng C
Horm Res; 1997; 47(4-6):168-78. PubMed ID: 9167949
[TBL] [Abstract][Full Text] [Related]
12. A novel germline point mutation, c.2304 G-->T, in codon 768 of the RET proto-oncogene in a patient with medullary thyroid carcinoma.
Antiñolo G; Marcos I; Fernández RM; Romero M; Borrego S
Am J Med Genet; 2002 Jun; 110(1):85-7. PubMed ID: 12116277
[No Abstract] [Full Text] [Related]
13. The newly detected mutations in the RET proto-oncogene in exon 16 as a cause of sporadic medullary thyroid carcinoma.
Jindrichova S; Kodet R; Krskova L; Vlcek P; Bendlova B
J Mol Med (Berl); 2003 Dec; 81(12):819-23. PubMed ID: 14618242
[TBL] [Abstract][Full Text] [Related]
14. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
Sansó G; Domené HM; Iorcansky S; Barontini M
Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
[TBL] [Abstract][Full Text] [Related]
15. Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation.
Gimm O; Neuberg DS; Marsh DJ; Dahia PL; Hoang-Vu C; Raue F; Hinze R; Dralle H; Eng C
Oncogene; 1999 Feb; 18(6):1369-73. PubMed ID: 10022819
[TBL] [Abstract][Full Text] [Related]
16. Mutation of the RET proto-oncogene is correlated with RET immunostaining in subpopulations of cells in sporadic medullary thyroid carcinoma.
Eng C; Thomas GA; Neuberg DS; Mulligan LM; Healey CS; Houghton C; Frilling A; Raue F; Williams ED; Ponder BA
J Clin Endocrinol Metab; 1998 Dec; 83(12):4310-3. PubMed ID: 9851769
[TBL] [Abstract][Full Text] [Related]
17. Thyroid carcinoma: diagnostic and therapeutic approach; genetic background (review).
Lewinski A; Ferenc T; Sporny S; Jarzab B
Endocr Regul; 2000 Jun; 34(2):99-113. PubMed ID: 10991553
[No Abstract] [Full Text] [Related]
18. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
Fink M; Weinhüsel A; Niederle B; Haas OA
Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874
[TBL] [Abstract][Full Text] [Related]
19. [Proto-oncogene RET somatic mutations in medullary thyroid carcinoma].
Wiench M; Kwaśniewski M; Gubała E; Wygoda Z; Pawlaczek A; Oczko M; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():415-21. PubMed ID: 12182058
[TBL] [Abstract][Full Text] [Related]
20. Genetic markers in thyroid neoplasia.
Puxeddu E; Fagin JA
Endocrinol Metab Clin North Am; 2001 Jun; 30(2):493-513, x. PubMed ID: 11444172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
